Relief Therapeutics (Switzerland) Market Value
| RLF Stock | CHF 5.00 0.06 1.21% |
| Symbol | Relief |
Relief Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Relief Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Relief Therapeutics.
| 06/05/2024 |
| 12/02/2024 |
If you would invest 0.00 in Relief Therapeutics on June 5, 2024 and sell it all today you would earn a total of 0.00 from holding Relief Therapeutics Holding or generate 0.0% return on investment in Relief Therapeutics over 180 days. Relief Therapeutics is related to or competes with VAT Group, Lonza Group, Basilea Pharmaceutica, Straumann Holding, and Santhera Pharmaceuticals. Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious dise... More
Relief Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Relief Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Relief Therapeutics Holding upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 7.56 | |||
| Information Ratio | 0.2189 | |||
| Maximum Drawdown | 75.45 | |||
| Value At Risk | (10.64) | |||
| Potential Upside | 23.15 |
Relief Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Relief Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Relief Therapeutics' standard deviation. In reality, there are many statistical measures that can use Relief Therapeutics historical prices to predict the future Relief Therapeutics' volatility.| Risk Adjusted Performance | 0.185 | |||
| Jensen Alpha | 2.98 | |||
| Total Risk Alpha | 0.7865 | |||
| Sortino Ratio | 0.367 | |||
| Treynor Ratio | (4.90) |
Relief Therapeutics Backtested Returns
Relief Therapeutics is dangerous given 3 months investment horizon. Relief Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.21, which implies the firm had a 0.21% return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 2.39% are justified by taking the suggested risk. Use Relief Therapeutics Semi Deviation of 6.19, coefficient of variation of 435.29, and Risk Adjusted Performance of 0.185 to evaluate company specific risk that cannot be diversified away. Relief Therapeutics holds a performance score of 16 on a scale of zero to a hundred. The company holds a Beta of -0.59, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Relief Therapeutics are expected to decrease at a much lower rate. During the bear market, Relief Therapeutics is likely to outperform the market. Use Relief Therapeutics semi variance, rate of daily change, and the relationship between the value at risk and kurtosis , to analyze future returns on Relief Therapeutics.
Auto-correlation | -0.2 |
Insignificant reverse predictability
Relief Therapeutics Holding has insignificant reverse predictability. Overlapping area represents the amount of predictability between Relief Therapeutics time series from 5th of June 2024 to 3rd of September 2024 and 3rd of September 2024 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Relief Therapeutics price movement. The serial correlation of -0.2 indicates that over 20.0% of current Relief Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.2 | |
| Spearman Rank Test | -0.52 | |
| Residual Average | 0.0 | |
| Price Variance | 2.82 |
Relief Therapeutics lagged returns against current returns
Autocorrelation, which is Relief Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Relief Therapeutics' stock expected returns. We can calculate the autocorrelation of Relief Therapeutics returns to help us make a trade decision. For example, suppose you find that Relief Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Relief Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Relief Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Relief Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Relief Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Relief Therapeutics Lagged Returns
When evaluating Relief Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Relief Therapeutics stock have on its future price. Relief Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Relief Therapeutics autocorrelation shows the relationship between Relief Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Relief Therapeutics Holding.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Relief Stock Analysis
When running Relief Therapeutics' price analysis, check to measure Relief Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relief Therapeutics is operating at the current time. Most of Relief Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relief Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relief Therapeutics' price. Additionally, you may evaluate how the addition of Relief Therapeutics to your portfolios can decrease your overall portfolio volatility.